Santiago Pelaez - Genomma Lab President
| LABB Stock | MXN 15.08 0.32 2.08% |
President
Mr. Santiago Velez Pelaez serves as Mexico Country Head and VicePresident of Manufacturing of Genomma Lab Internacional, S.A.B. de C.V. since 2016. He joined Genomma Lab after completed the position of General Manager very successfully at Quala Mexico. His professional career encompasses 23 years of experience in this company, occupying different positions in the Marketing area in Colombia, where he became Area Director, later to be CEO of the same company in Venezuela, Dominican Republic and finally in Mexico, achieving excellent sales results. He holds a degree in Industrial Engineering from Pontifica Universidad Javeriana and Masters degree in Marketing from Universidad de Los Andes. since 2018.
| Tenure | 6 years |
| Phone | 52 55 5081 0000 |
| Web | https://www.genommalab.com |
Genomma Lab Management Efficiency
The company has return on total asset (ROA) of 0.0921 % which means that it generated a profit of $0.0921 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1264 %, meaning that it generated $0.1264 on every $100 dollars invested by stockholders. Genomma Lab's management efficiency ratios could be used to measure how well Genomma Lab manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 6 records | PRESIDENT Age | ||
| Alejandro Barragan | Alfa SAB de | 64 | |
| Carlos Barrera | Alfa SAB de | 68 | |
| Paulino Mendivil | Alfa SAB de | 68 | |
| Alvaro Garza | Alfa SAB de | 55 | |
| Alfredo Perez | Grupo Mxico SAB | 70 | |
| Daniel Quintanilla | Grupo Mxico SAB | 43 | |
Management Performance
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0921 |
Genomma Lab Internacional Leadership Team
Elected by the shareholders, the Genomma Lab's board of directors comprises two types of representatives: Genomma Lab inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genomma. The board's role is to monitor Genomma Lab's management team and ensure that shareholders' interests are well served. Genomma Lab's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genomma Lab's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Maximo Juda, CEO, COO and Executive Vice-Pres | ||
| Scott Emerson, Independent Director | ||
| Stefano Curti, Global President of Brands | ||
| Cesar Lopez, Vice President of Global Marketing | ||
| Efran Crdova, Deputy Sec | ||
| Ramon Sastre, Executive Vice President of Institutional Relations | ||
| Carlos Alonso, Independent Director | ||
| Marianne Velasco, Global HR | ||
| Marco Munoz, Non-Member Secretary of the Board of Directors | ||
| Jorge Munoz, Independent Director | ||
| Ignacio Rodriguez, Independent Director | ||
| Alejandro Patino, Executive Vice President of Human Capital and Commercial Expansion | ||
| L Porres, Legal Officer | ||
| Leandro Gold, Independent Director | ||
| Jose Fernandez, Independent Director | ||
| Rodrigo Aspra, Chairman of the Board, Independent Director | ||
| Claudia Vettoretti, Vice-President of Marketing | ||
| Renata Aspra, COO and Executive Vice-Pres | ||
| Juan Gavito, Independent Director | ||
| Antonio Galland, Executive Vice President, Chief Financial and Chief Administrative Officer | ||
| Luis MacKissack, Director | ||
| Arturo Perez, Director | ||
| Hector Gonzalez, Independent Director | ||
| Burkhard Wittek, Director | ||
| Alejandro Patio, Media, Relations | ||
| Marco Sparvieri, Executive Vice-President of Global Sales | ||
| Javier Castilla, Independent Director | ||
| Engineer Galland, Exec CFO | ||
| Sabrina Aspra, Director of International Operations, Director | ||
| Mximo Juda, Advisor | ||
| Daniel Neria, Head Relations | ||
| Juan Alonso, Independent Director | ||
| Santiago Pelaez, Vice President of Industrial and Research and Development | ||
| Jorge Valderrama, Chief Executive Officer | ||
| Juan Sparvieri, Chief Operating Officer, Vice President | ||
| Roberto Sauma, Independent Director | ||
| Leticia Herrera, Global Director of Human Resources (Genomma Experience) |
Genomma Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genomma Lab a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0921 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 20.43 B | |||
| Shares Outstanding | 1 B | |||
| Shares Owned By Insiders | 29.00 % | |||
| Shares Owned By Institutions | 29.10 % | |||
| Price To Earning | 13.61 X | |||
| Price To Book | 1.51 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Genomma Lab in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Genomma Lab's short interest history, or implied volatility extrapolated from Genomma Lab options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Genomma Lab Internacional. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Genomma Stock analysis
When running Genomma Lab's price analysis, check to measure Genomma Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genomma Lab is operating at the current time. Most of Genomma Lab's value examination focuses on studying past and present price action to predict the probability of Genomma Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genomma Lab's price. Additionally, you may evaluate how the addition of Genomma Lab to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |